Successful fibrinolysis after acute left ventricular assist device thrombosis.
The Berlin Heart INCOR system (Berlin Heart AG, Berlin, Germany) is a left ventricular assist device that generates a laminar blood flow. One of our INCOR-implanted patients was admitted to the hospital with clinical data indicating device thrombosis. The flow through the pump was assessed by contrast injection into the inflow canula. Lack of flow through the pump was found. A decision was made to perform fibrinolysis, which was performed by a reteplase injection into the device's inflow canula. After the manipulation, a restoration of the flow through the pump was observed. The patient was discharged 9 days after the procedure with no complications.
Tschirkov
Alexander
A
Department of Cardiac Surgery, St. Ekaterina University Hospital, Sofia, Bulgaria.
Nikolov
Dimitar
D
Tasheva
Iveta
I
Papantchev
Vassil
V
D000208:Acute Disease; D000328:Adult; D004359:Drug Therapy, Combination; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008382:Marfan Syndrome / Q000175:diagnosis / Q000601:surgery; D018570:Risk Assessment; D015912:Thrombolytic Therapy / Q000379:methods*; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D005343:Fibrinolytic Agents